PAINFUL DIABETIC PERIPHERAL NEUROPATHY : A STEPWISE APPROACH TO TREATMENT

@article{Js1994PAINFULDP,
  title={PAINFUL DIABETIC PERIPHERAL NEUROPATHY : A STEPWISE APPROACH TO TREATMENT},
  author={James Js and Page Jc},
  journal={Journal of the American Podiatric Medical Association},
  year={1994},
  volume={84},
  pages={439-447}
}
  • James Js, Page Jc
  • Published 1994
  • Medicine
  • Journal of the American Podiatric Medical Association
The stepwise approach to the treatment of painful diabetic peripheral neuropathy allows the practitioner to use a broad spectrum of therapeutic modalities and physiologic approaches to this complicated clinical problem. The authors review the etiology and clinical presentation of diabetic neuropathy. Available therapeutic alternatives are discussed and an original stepwise algorithm is presented. Pharmacologic profiles of the most commonly used drugs are also described. 
Chronic neuropathic pain and its control by drugs.
TLDR
Evidence suggests that many neurogenic pain states are not effectively controlled, due in part to a lack of understanding of the aetiology of these conditions and to the lack of high quality studies evaluating existing treatments. Expand
Selective Nerve Root Stimulation (SNRS) in the Treatment of End‐Stage, Diabetic, Peripheral Neuropathy: A Case Report
  • K. Aló, A. Zidan
  • Medicine
  • Neuromodulation : journal of the International Neuromodulation Society
  • 2000
TLDR
The possibility of utilizing epidural, peripheral neurostimulation was investigated in a patient with endstage, diabetic, “dying back” peripheral SIP, and it was found that peripheral nerve stimulation (PNS) has successfully treated certain SIP presentations. Expand
Is electrical stimulation effective in reducing neuropathic pain in patients with diabetes?
TLDR
The results of this pilot study suggest that nocturnal doses of pulsed-electrical stimulation may be effective in alleviating subjective, burning, diabetic neuropathic pain in a population consisting of patients with grossly intact protective sensation, relatively good distal vascular perfusion and less than ideal glucose control. Expand
A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin
Neuropathic vulvodynia is a state of vulval discomfort characterized by a burning sensation, diffuse pain, pruritus or rawness with an acute or chronic onset. Diabetes mellitus may cause this type ofExpand
Symptomatische Behandlung schmerzhafter diabetischer Neuropathien
TLDR
Vorweggenommen sei, daß es in der analgetischen Therapie auch bei Neuropathien keine Patentrezepte and bindenden Empfehlungen geben kann, die sich an Algorithmen ablesen lassen. Expand
Neurogenic Pain Disorder in the Foot and Ankle: Peripheral Neuropathy
TLDR
It is confirmed that Charcot-Marie-Tooth disease is the leading cause of death in children aged under the age of five in Europe. Expand
Symptomatische Behandlung schmerzhafter diabetischer Neuropathien
TLDR
Die Auswahl medikamentöser Behandlungsmöglichkeiten ist so groß, dass man für jeden Patienten aus der Vielzahl der Substanzen, deren Wirksamkeit mehr oder weniger gut belegt ist, ein geeignetes Präparat findet. Expand
Diabetes Increases the Analgesia and Tolerance to Morphine in Acute Pain, but Not in Chronic Pain, While it Attenuates the Dependency in Rats
TLDR
During the progress of diabetes, hyperglycemia might diminish the analgesic effect of morphine, blunt the development of dependency and alter the induction of tolerance. Expand
Gabapentin and the Neurokinin1 Receptor Antagonist CI-1021 Act Synergistically in Two Rat Models of Neuropathic Pain
TLDR
A synergistic interaction between gabapentin and NK1 receptor antagonists in animal models of neuropathic pain is suggested. Expand
Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat.
TLDR
It is suggested that the central NK1 receptor may play an important role in diabetes-induced hypersensitivity and that PD 156982 can effectively antagonize peripheral NK1 receptors in vivo. Expand
...
1
2
...